All Articles, News & Resources

Search, filter, and explore articles, updates, and tools that support better oversight.

Scroll

All Articles, News & Resources

Search, filter, and explore articles, updates, and tools that support better oversight.

Cyntegrity logo – Risk-Based Quality Management Solutions

Trending Now: Most-Read by Clinical Teams

Trending Now: Most-Read by Clinical Teams

ICH E6(R3) Sponsor Responsibilities: What’s New and What It Means for You

Understand sponsor responsibilities under ICH E6(R3) and how to meet modern GCP expectations using risk-based,

5 Key Questions to Ask When Evaluating RBQM Platforms (ICH E6(R3)-Ready)

Learn the 5 essential evaluation questions when comparing RBQM systems. Ensure transparency, traceability, collaboration, and

Risk-based quality management in 2026

Risk-based quality management in 2026: how ICH E6(R3) defines RBQM, where practice diverges, and what

Quality Tolerance Limits (QTLs) in Clinical Trials

Quality tolerance limits (QTLs) define when trial performance risks safety or data integrity. This guide

Phase III Oncology: Targeted Risk-Based QA Case Study

How ADAMAS used AI-augmented RBQM analytics to strengthen oversight, focus QA effort, and improve inspection readiness in a global Phase III oncology study....

Site Readiness Under ICH E6(R3) 

Key expectations for site readiness under ICH E6(R3), including documentation, risk-based oversight, and digital data governance. ...

ICH E6(R3) Final Guideline: What You Need to Know

ICH E6(R3) is now adopted. Learn what changes for sponsors, CROs, and sites, including accountability, CtQ planning, proactive monitoring, and participant protection. ...

Site Readiness Tips

Practical steps trial sites can take to align with ICH E6(R3) expectations for training, data governance, and risk-based monitoring. ...

All Articles News & Resources

These pages are meant to:
Attract talent aligned with your mission and additionally mindset.
Show that Cyntegrity is a company people want to work with — especially and work for.
but, Provide assurance to enterprise clients that you align with modern values (ESG, ethics, diversity).

INDUSTRY SOLUTIONS page is focused on regulatory assurance, and especially its goal is to build trust. And remove perceived risk from decision-makers like Project, Program, Operations leads, QA leads, regulatory officers, clinical compliance managers, and procurement teams.

Trusted Compliance page is focused on regulatory assurance, and additionally its goal is to build trust and remove perceived risk from decision-makers. like QA leads, regulatory officers, clinical compliance managers, and procurement teams, but.

Key Capabilities pages are meant to tease our technical and especially operational capabilities, but not overwhelm. but, They should:
Show how it works, Prove interoperability, Make it easy to request technical info (not deliver it all upfront)

Connect & Deploy – These are deeper technical capabilities. Visitors here are:
Clinical data leads.
IT/integration specialists.
Ops leaders trying to understand if your platform plugs into theirs.
These pages also must communicate technical readiness but still follow your “teaser-first. CTA-driven” rule — no docs, SDKs, or especially schemas upfront.

Compliance Snapshot pages are all about building trust and especially accelerating vendor approval. Their job is to reassure IT security leads, QA managers. And procurement that Cyntegrity is fully compliant, auditable, and secure especially.
These are not product pages — they are trust assets. Also They should be simple, scannable, and downloadable especially.
These are not sales pages — also, they are trust accelerators for decision-makers who ask.
“Is this vendor secure, validated, and certified?”

All Articles News & Resources

Guest Speaker

Brian Barnes

BioNTech

Presented By

Dr. Johann Proeve

Cyntegrity

Presented By

Keith Doricott, MBB

Dorricott Metrics

Let's get AI doing the work in RBQM

Unlock AI-powered RBQM, understand its impact, and put it to work in your processes today.

Date

11 March 2026